News
Latest News
Contact Us
‘Thank You LifeCell & Community Cord Blood Banking!’ said Little Gauri’s Parents
26/12/2022
Parent’s Guide to Cord Blood, November 2022 Gauri (name changed) was diagnosed with Beta-Thalassemia Major seven years ago. Thalassemia is a hereditary disorder which causes
Immune system reboot in MS patients
22/12/2022
Science Daily, November 10, 2022 Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. A study led by the University
Monoclonal antibodies preserve stem cells in mouse brains, bring promise for future studies
20/12/2022
Science Daily, November 9, 2022 A new approach to stem cell therapy that uses antibodies instead of traditional immunosuppressant drugs robustly preserves cells in mouse
Researchers develop novel platform to improve immunotherapy
16/12/2022
Potential clinical applications include oncology and autoimmune diseases Science Daily, November 3, 2022 Recent advances in immunotherapy for cancer have stimulated a plethora of studies
Landmark clinical trial aims to treat spina bifida before birth
14/12/2022
News-Medical, Oct 7, 2022 Reviewed by Emily Henderson, B.Sc. Three babies have been born after receiving the world’s first spina bifida treatment combining surgery with stem
Study uncovers mechanisms of reactive oxygen species in stem cell function and inflammation prevention
12/12/2022
Findings could improve prevention and treatment of inflammatory bowel diseases Science Daily, October 3, 2022 Mount Sinai researchers have published one of the first studies
From Japan to Duke: Cord Blood for HIE
28/11/2022
Parent’s Guide to Cord Blood, October 2022 Anonymous Parents The following story tells the experiences and impressions of a family that stored umbilical cord blood
The story behind FamiCord becoming the largest cord blood bank in Europe
25/11/2022
Parent’s Guide to Cord Blood, October 2022 Tomasz Baran, MD MBA Cord blood banking in Europe is 25 years old. In 1997, the first family
Stem cell-gene therapy shows promise in ALS safety trial
22/11/2022
Science Daily, September 5, 2022 Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the
